Structure Info
- Chemspace ID
- CSSS00000736165 (In-Stock Screening Compounds)
- CAS
- 134029-62-2
- MFCD
- MFCD03427315
- IUPAC Name
- 1,2,3-trimethoxy-5-[(1E)-2-(4-methoxyphenyl)ethenyl]benzene
- Mol formula
- C18H20O4
- Mol weight
- 300 Da
- Catalog Number(s)
- 134029-49-5, A577431, AA009JOU, ACM134029495, AE45322, AG009JRM, AR009KGM, BD161471, CSC000736165, EN300-21686167, FT66531, G13205, HY-137977, LN04604631, M28078, MS-24329, Q65678, T298908, T36674, U74814, Y3141586, ZXC243381
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.68
- Heavy atoms count
- 22
- Rotatable bond count
- 6
- Number of rings
- 2
- Carbon bond saturation, Fsp3
- 0.222
- Polar surface area (Å)
- 37
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 0
- Zoom the structure
- CSSS00000736165
Items Overall 17 items from 3 suppliers
Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
---|---|---|---|---|---|---|
MedChemExpress | 10 days | United States To: | 99 | 5 mg | 62 | |
MedChemExpress | 10 days | United States To: | 99 | 10 mg | 100 | |
MedChemExpress | 10 days | United States To: | 99 | 25 mg | 200 | |
MedChemExpress | 10 days | United States To: | 99 | 50 mg | 350 | |
MedChemExpress | 10 days | United States To: | 99 | 10mM/1mL | 68 | |
Description: Names: DMU-212; Product Description: DMU-212 is a methylated derivative of Resveratrol (HY-16561), with antimitotic, anti-proliferative, antioxidant and apoptosis promoting activities. DMU-212 induces mitotic arrest via induction of apoptosis and activation of ERK1/2 protein. DMU-212 has orally active .; Target: Apoptosis;ERK; CAS: 134029-62-2 | ||||||
MedChemExpress EU | 10 days | Sweden To: | 99 | 5 mg | 65 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 10 mg | 105 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 25 mg | 211 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 50 mg | 369 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 10mM/1mL | 71 | |
Description: Names: DMU-212; Product Description: DMU-212 is a methylated derivative of Resveratrol (HY-16561), with antimitotic, anti-proliferative, antioxidant and apoptosis promoting activities. DMU-212 induces mitotic arrest via induction of apoptosis and activation of ERK1/2 protein. DMU-212 has orally active; Target: Apoptosis;ERK; CAS: 134029-62-2 | ||||||
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 2 mg | 30 | |
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 5 mg | 48 | |
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 10 mg | 80 | |
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 25 mg | 163 | |
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 50 mg | 288 | |
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 100 mg | 428 | |
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 500 mg | 969 | |
Description: DMU-212 is a methylated derivative of resveratrol with antimitotic, anti-proliferative, antioxidant, and apoptosis-promoting activities. It induces mitotic arrest, apoptosis, and activation of ERK1/2 protein and has oral activity[1][2]. DMU-212 (0.3125-40 μM) inhibits the growth of human melanoma cells (A375, MeWo, Bro, M5)[1]. At concentrations of 30-50 μM over 24 hours, it upregulates cell cycle inhibitors, induces apoptosis, and activates ERK in A375 cells[1]. DMU-212 also induces G2/M arrest and apoptosis in cancer cells[1]. In a xenograft model of human ovarian cancer with six-week-old SCID female mice (20-24 g), DMU-212 (50 mg/kg, administered orally three times a week for 14 days) inhibits tumor growth[2]. [1]. Vasilis Pericles Androutsopoulos, et al. Activation of ERK1/2 is required for the antimitotic activity of the resveratrol analogue 3,4,5,4'-tetramethoxystilbene (DMU-212) in human melanoma cells. Exp Dermatol. 2015 Aug;24(8):632-4. [2]. Hanna Piotrowska, et al. DMU-212 inhibits tumor growth in xenograft model of human ovarian cancer. Biomed Pharmacother. 2014 May;68(4):397-400.; CAS: 134029-62-2 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire